Prestige Consumer Healthcare (PBH) Tax Provisions (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Tax Provisions of $15.1 million in Q4 2025, down 43.85% quarter-over-quarter from $26.9 million in Q3 2025, and down 20.94% on a YoY basis from $19.1 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Tax Provisions (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Tax Provisions history runs 16 years deep, the most recent figure standing at $15.1 million for Q4 2025.
- In Q4 2025, Tax Provisions fell 20.94% year-over-year to $15.1 million; the TTM figure through Dec 2025 stood at $80.2 million (up 26.04% YoY), while the FY2025 annual figure was $69.6 million, up 4.35% from the prior year.
- Tax Provisions was $15.1 million for Q4 2025 at Prestige Consumer Healthcare, down from $26.9 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $26.9 million in Q3 2025 to a low of -$59.0 million in Q1 2023.
- Historically, Tax Provisions has averaged $12.1 million across 5 years, with a median of $15.6 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions plunged 764.15% in 2023, then surged 130.29% in 2024.
- A 5-year view of Tax Provisions shows it stood at $15.3 million in 2021, then rose by 5.81% to $16.2 million in 2022, then gained by 2.25% to $16.5 million in 2023, then gained by 15.69% to $19.1 million in 2024, then dropped by 20.94% to $15.1 million in 2025.
- The last three Tax Provisions figures came in at $15.1 million (Q4 2025), $26.9 million (Q3 2025), and $14.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -3.57 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 48.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.44 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 37.99 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.12 Mn |
| Sep 30, 2025 | 26.92 Mn |
| Jun 30, 2025 | 14.31 Mn |
| Mar 31, 2025 | 23.83 Mn |
| Dec 31, 2024 | 19.12 Mn |
| Sep 30, 2024 | 17.29 Mn |
| Jun 30, 2024 | 9.35 Mn |
| Mar 31, 2024 | 17.86 Mn |
| Dec 31, 2023 | 16.53 Mn |
| Sep 30, 2023 | 16.86 Mn |
| Jun 30, 2023 | 15.44 Mn |
| Mar 31, 2023 | -58.97 Mn |
| Dec 31, 2022 | 16.17 Mn |
| Sep 30, 2022 | 15.57 Mn |
| Jun 30, 2022 | 15.63 Mn |
| Mar 31, 2022 | 8.88 Mn |
| Dec 31, 2021 | 15.28 Mn |
| Sep 30, 2021 | 14.31 Mn |
| Jun 30, 2021 | 18.62 Mn |
| Mar 31, 2021 | 4.86 Mn |